Market Cap 14.32B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 27.17
Forward PE 21.36
Profit Margin -27.97%
Debt to Equity Ratio 0.63
Volume 3,182,200
Avg Vol 2,171,952
Day's Range N/A - N/A
Shares Out 158.30M
Stochastic %K 88%
Beta 1.32
Analysts Sell
Price Target $109.43

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
harmongreg
harmongreg Jun. 22 at 3:19 PM
5 Trade Ideas for Monday: Bank of America, Caterpillar, CME, Illumina and Norfolk Southern https://dragonflycap.com/5-trade-ideas-for-monday-bank-of-america-caterpillar-cme-illumina-and-norfolk-southern/ $BAC $CAT $CME $ILMN $NSC
0 · Reply
LittleJohn213
LittleJohn213 Jun. 21 at 1:32 AM
$ILMN Held up like a champ today👍
0 · Reply
LittleJohn213
LittleJohn213 Jun. 20 at 2:17 PM
$ILMN Yesterday spoke with my neighbor about tickers I’m holding and also ones I’m watching for entry and he looked at their charts. Only charts he liked are this one and ADBE. Months ago I mentioned ILMN but he didn’t care for it then but now he’s interested after looking at chart yesterday.
2 · Reply
LittleJohn213
LittleJohn213 Jun. 19 at 4:08 PM
$ILMN This POS finally showing some life.
1 · Reply
Simp_Slayer
Simp_Slayer Jun. 17 at 5:48 PM
$ILMN yaaa, still holding 🤙
0 · Reply
DonCorleone77
DonCorleone77 Jun. 16 at 12:37 AM
$QGEN $INCY $ILMN Qiagen, Incyte announce collaboration to develop companion diagnostics QIAGEN (QGEN) and Incyte (INCY) announced a new global collaboration to develop a novel diagnostic panel to support Incyte's extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms, a group of rare blood cancers, including Incyte's monoclonal antibody INCA033989, targeting mutant calreticulin, which is being developed in myelofibrosis and essential thrombocythemia. Under the terms of the Master Collaboration Agreement with Incyte, QIAGEN will develop a multimodal panel using next-generation sequencing technology for detecting clinically relevant gene alterations in hematological malignancies. The panel will be validated using the next-generation sequencing technology and the Illumina NextSeq 550Dx platform as part of QIAGEN's partnership with Illumina (ILMN) to leverage its NGS diagnostic platforms for patient testing by laboratories worldwide. QIAGEN will support regulatory submission processes and market access activities across the United States, European Union and Asia-Pacific regions.
0 · Reply
HomesteadInvestor
HomesteadInvestor Jun. 15 at 11:46 PM
$ILMN is selling shovels in the gold rush of genomics.
1 · Reply
ZacksResearch
ZacksResearch Jun. 13 at 5:45 PM
$TEM's strategic moves are paying off — but is the valuation too rich? 🤔 🚀 Shares surged 77% over the past year, outpacing the industry's 39.7% growth. 💡 Recent partnerships with $AZN and $ILMN focus on expanding relationships and enhancing AI-driven precision medicine technologies. 📉 Yet, it's trading at a forward P/S of 8.85x vs. the industry's 6.34x and holds a Value Score of F. Dive into the full analysis here 👉 https://www.zacks.com/commentary/2498512/tempus-ais-expanding-ties-boost-novel-rd-efforts-and-market-reach?cid=sm-stocktwits-2-2498512-body&ADID=SYND_STOCKTWITS_TWEET_2_2498512_BODY
0 · Reply
Jakestonks
Jakestonks Jun. 13 at 1:14 AM
$ILMN what the hell does Isreal bombing Iran have to do with this stock?? 5% drop???
2 · Reply
tarzzanman
tarzzanman Jun. 12 at 11:43 AM
$ILMN So oversold no sellers left..?
1 · Reply
Latest News on ILMN
Illumina To Webcast Upcoming Investor Conference

May 14, 2025, 4:05 PM EDT - 5 weeks ago

Illumina To Webcast Upcoming Investor Conference


Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 5 weeks ago

Illumina Analysts Lower Their Forecasts After Q1 Results


Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 6 weeks ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025


Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 6 weeks ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript


Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Mar 27, 2025, 8:35 AM EDT - 3 months ago

Is Illumina Undervalued After An 83% Drop In Its Stock Price?


Activist Investor Meister to Join Illumina's Board

Mar 25, 2025, 8:00 AM EDT - 3 months ago

Activist Investor Meister to Join Illumina's Board


Illumina addresses recent developments in China

Mar 10, 2025, 4:10 PM EDT - 3 months ago

Illumina addresses recent developments in China


China bans imports of Illumina's gene sequencers

Mar 4, 2025, 12:57 AM EST - 3 months ago

China bans imports of Illumina's gene sequencers


Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 4 months ago

Trump's Cuts to Medical Research Are Hurting These Stocks

PACB TXG


Illumina Analysts Slash Their Forecasts Following Q4 Results

Feb 7, 2025, 2:22 PM EST - 4 months ago

Illumina Analysts Slash Their Forecasts Following Q4 Results


Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 9:33 PM EST - 4 months ago

Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript


Illumina forecasts 2025 revenue largely below estimates

Feb 6, 2025, 4:42 PM EST - 4 months ago

Illumina forecasts 2025 revenue largely below estimates


China puts PVH Corp, Illumina on its unreliable entity list

Feb 4, 2025, 12:57 AM EST - 4 months ago

China puts PVH Corp, Illumina on its unreliable entity list

PVH


harmongreg
harmongreg Jun. 22 at 3:19 PM
5 Trade Ideas for Monday: Bank of America, Caterpillar, CME, Illumina and Norfolk Southern https://dragonflycap.com/5-trade-ideas-for-monday-bank-of-america-caterpillar-cme-illumina-and-norfolk-southern/ $BAC $CAT $CME $ILMN $NSC
0 · Reply
LittleJohn213
LittleJohn213 Jun. 21 at 1:32 AM
$ILMN Held up like a champ today👍
0 · Reply
LittleJohn213
LittleJohn213 Jun. 20 at 2:17 PM
$ILMN Yesterday spoke with my neighbor about tickers I’m holding and also ones I’m watching for entry and he looked at their charts. Only charts he liked are this one and ADBE. Months ago I mentioned ILMN but he didn’t care for it then but now he’s interested after looking at chart yesterday.
2 · Reply
LittleJohn213
LittleJohn213 Jun. 19 at 4:08 PM
$ILMN This POS finally showing some life.
1 · Reply
Simp_Slayer
Simp_Slayer Jun. 17 at 5:48 PM
$ILMN yaaa, still holding 🤙
0 · Reply
DonCorleone77
DonCorleone77 Jun. 16 at 12:37 AM
$QGEN $INCY $ILMN Qiagen, Incyte announce collaboration to develop companion diagnostics QIAGEN (QGEN) and Incyte (INCY) announced a new global collaboration to develop a novel diagnostic panel to support Incyte's extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms, a group of rare blood cancers, including Incyte's monoclonal antibody INCA033989, targeting mutant calreticulin, which is being developed in myelofibrosis and essential thrombocythemia. Under the terms of the Master Collaboration Agreement with Incyte, QIAGEN will develop a multimodal panel using next-generation sequencing technology for detecting clinically relevant gene alterations in hematological malignancies. The panel will be validated using the next-generation sequencing technology and the Illumina NextSeq 550Dx platform as part of QIAGEN's partnership with Illumina (ILMN) to leverage its NGS diagnostic platforms for patient testing by laboratories worldwide. QIAGEN will support regulatory submission processes and market access activities across the United States, European Union and Asia-Pacific regions.
0 · Reply
HomesteadInvestor
HomesteadInvestor Jun. 15 at 11:46 PM
$ILMN is selling shovels in the gold rush of genomics.
1 · Reply
ZacksResearch
ZacksResearch Jun. 13 at 5:45 PM
$TEM's strategic moves are paying off — but is the valuation too rich? 🤔 🚀 Shares surged 77% over the past year, outpacing the industry's 39.7% growth. 💡 Recent partnerships with $AZN and $ILMN focus on expanding relationships and enhancing AI-driven precision medicine technologies. 📉 Yet, it's trading at a forward P/S of 8.85x vs. the industry's 6.34x and holds a Value Score of F. Dive into the full analysis here 👉 https://www.zacks.com/commentary/2498512/tempus-ais-expanding-ties-boost-novel-rd-efforts-and-market-reach?cid=sm-stocktwits-2-2498512-body&ADID=SYND_STOCKTWITS_TWEET_2_2498512_BODY
0 · Reply
Jakestonks
Jakestonks Jun. 13 at 1:14 AM
$ILMN what the hell does Isreal bombing Iran have to do with this stock?? 5% drop???
2 · Reply
tarzzanman
tarzzanman Jun. 12 at 11:43 AM
$ILMN So oversold no sellers left..?
1 · Reply
JarvisFlow
JarvisFlow Jun. 11 at 12:00 PM
Canaccord Genuity has updated their rating for Illumina ( $ILMN ) to Hold with a price target of 99.
0 · Reply
mstan
mstan Jun. 10 at 10:25 PM
$ILMN https://finance.yahoo.com/news/lllumina-releases-2024-corporate-social-200100109.html
0 · Reply
swingingtech
swingingtech Jun. 10 at 8:06 PM
$URI $ILMN $SSTK https://wallstreetwaves.com/significant-tuesday-options-activity-uri-ilmn-sstk/
0 · Reply
StockHunter75
StockHunter75 Jun. 10 at 6:20 PM
$ILMN bought the dip holding long term.
0 · Reply
mstan
mstan Jun. 10 at 4:54 PM
$ILMN 🤔
0 · Reply
Sunny8393284923
Sunny8393284923 Jun. 10 at 3:12 PM
$ILMN 5 year hold.
0 · Reply
Michael_MDC
Michael_MDC Jun. 10 at 2:58 PM
$ILMN let’s see where she closes but for now , harmonic activated
0 · Reply
KathleenCole442
KathleenCole442 Jun. 10 at 12:50 PM
My $BGM position and $ILMN's sequencing tech have one thing in common - they both promise to decode the future while giving me heartburn today.
0 · Reply
roger120
roger120 Jun. 7 at 6:40 PM
$VERV $CRSPR $NTLA $QURE $ILMN Blockbuster statement that likely launches this field to the moon.
2 · Reply
Estimize
Estimize Jun. 3 at 3:00 PM
Wall St is expecting 1.01 EPS for $ILMN Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_co
0 · Reply
GreenPond
GreenPond May. 31 at 9:28 PM
$LAB $ILMN Getting closer to the Commercial launch “Illumina Protein Prep: New Era of Proteomics” “At GeneTiCA Group, we have fully implemented and validated the Illumina Protein Prep (IPP) workflow” “From Sample to High-Quality Data in Under 2.5 Days. Illumina Protein Prep integrates SOMAmer® reagents with Illumina Next-Generation Sequencing (NGS), enabling highly multiplexed protein quantification through a scalable workflow. https://www.genetica.cz/illumina-protein-prep-new-era-of-proteomics
1 · Reply
goldilucks
goldilucks May. 30 at 6:51 PM
$ILMN trading like a tight wet fart all the way to next Q, wouldn't expect anything less
0 · Reply